Mikroalbuminüri, Kritik Uzuv İskemisi Sebebi ile Diz Altı Arterlere Uygulanan Endovasküler Tedavide Restenoz İçin Risk Faktörü Değildir.

Türkçe

Objective: The aim of this study was to determine whether microalbuminuria (MA) is predictive of restenosis in patients with below the knee artery (BTK) disease and treated with endovascular therapy (EVT). Method: We retrospectively identified patients from May 2012 to September 2016 at our clinic with severely diseased BTK arteries successfully treated by endovascular approach and measured microalbuminuria (MA) recently before intervention. All patients had ankle-brachial index (ABI) measured before and after the intervention, and regular clinical follow-up with Doppler ultrasonography performed at 1 month, 6 months and 1 year. Patients underwent peripheral angiography if needed. Results: 46 patients with BTK arteries critical stenosis or occlusion treated with endovascular therapy and measurement of MA (through three months before intervention) in our institute were included. Patients were divided into two groups with MA and MA not seen (MANS). There were 8 restenosis in the MA group (63.6% patency rate) and 5 restenosis in the MANS group (77.3 % patency rate) at 1 year (p=0.517). There were four minor amputations in MA group (17.4 %) and three minor amputations in MANS group (13.0 %, p=1.000). A statistically significant increase in the ABI (MA before 0.45±0.11 vs. after 0.89±0.08 p<0.01 MANS before 0.43±0.10 vs. after 0.89±0.07 p<0 . 01) and improvement in Rutherford staging (p<0.01) was noted in both groups following intervention. Conclusion: MA is not a predictive factor for restenosis or amputation rate in patients with BTK arterial disease treated with endovascular therapy